FibroBiologics implements 1-for-20 reverse stock split effective March 30, 2026

FibroBiologics, Inc.

Reverse split ratio of 1:20; every 20 shares converted to 1 share.
No fractional shares issued; any fractional interests rounded up to the nearest whole share.
Par value unchanged at $0.00001; authorized shares unchanged.
CUSIP changed to 31573L204; trading symbol remains 'FBLG'.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.